Halliburton Company HAL
Verdict: Hold. Fair value $32.87 against a price of $31.92 on 6 Jan 2026, 3% above the price.
In plain words
The case for: Narrow competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins. Company has met earnings estimates exactly in 3 of the last 4 reported quarters (0.0% surprise).....
Main risks
- Revenue Deceleration: After a strong recovery, revenue growth has turned negative in the latest annual period (-0.3%) and TTM figures confirm a slowdown, indicating a potential cyclical peak.
- Moderate Leverage: A Debt/Equity ratio of 0.82 and a proxy Net Debt/EBITDA of 2.7x are notable for a cyclical business, potentially increasing financial risk during industry downturns.
- Inconsistent Data Proxies: The provided TTM Proxy EBIT ($2.10B) is significantly lower than the latest annual Net Income ($2.50B), which is highly unusual and reduces confidence in EBIT-based metrics like ROIC and ROIIC.
- Intense competitive environment
- Overhang: The 'long road ahead' for Venezuela's oil industry revival. While immediate hopes are high...